It is high time for Europe to break its relative decline in the pharmaceutical sector. Europe used to be the preeminent region in the world for Research and Development and innovation in the sector - being the location for a majority of R&D and the development of new medicines. However, its...

While innovation is central for the quality of healthcare and improving health outcomes, it is also a source of increasing costs for governments. Confronted by fiscal pressures, governments have made efforts to restrict access to innovative treatments. While such policies are understandable,...

A big part of the EU-US productivity gap is due to the EU investing less in ICT-related tangible and intangible capital. These lower investments are partly explained by EU digital regulations limiting companies' access to modern endowments like data. Limits to these endowments push EU firms...

While innovation is central for the quality of healthcare and improving health outcomes, it is also a source of increasing costs for governments. Confronted by fiscal pressures, governments have made efforts to restrict access to innovative treatments. While such policies are understandable,...

The EU stands at a crucial economic juncture. Economic growth in Europe's mature economies has stagnated, with productivity and other indicators of economic vitality showing poor results. Public debt is alarmingly high in several countries, and the region faces new fiscal demands due to an...

In this study on the transformative potential of quantum technology in reshaping economies, we present results and evidence drawing on a unique and innovative quantum dataset compiled by ECIPE. This data offers new insights into the current state of quantum advancements. This comprehensive...

Cover page -- Halftitle page -- Title page -- Copyright page -- CONTENTS -- LIST OF FIGURES -- PREFACE -- ACKNOWLEDGMENTS -- 1 INTRODUCTION -- The planning machine -- Bound capitalism -- The four horsemen of capitalist decline -- 2 WHEN CAPITALISM BECAME MIDDLE-AGED -- The bridges to Maddison...

It is high time for Europe to break its relative decline in the pharmaceutical sector. Europe used to be the preeminent region in the world for Research and Development and innovation in the sector - being the location for a majority of R&D and the development of new medicines. However, its...

Timely, compelling, and certain to be controversial—a deeply researched study that reveals how companies and policy makers are hindering innovation-led growth Conventional wisdom holds that Western economies are on the threshold of fast-and-furious technological development. Fredrik Erixon and...